Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
The current price of ACON is $3.57 USD — it has increased by +9.02% in the past 24 hours. Watch Aclarion stock price performance more closely on the chart.
What is Aclarion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aclarion stocks are traded under the ticker ACON.
Is Aclarion stock price growing?▼
ACON stock has risen by +6.5% compared to the previous week, the month change is a +25.55% rise, over the last year Aclarion has showed a -69.58% decrease.
What is Aclarion market cap?▼
Today Aclarion has the market capitalization of 2.39M
When is the next Aclarion earnings date?▼
Aclarion is going to release the next earnings report on June 03, 2026.
What were Aclarion earnings last quarter?▼
ACON earnings for the last quarter are -2.56 USD per share, whereas the estimation was -3.6 USD resulting in a +28.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aclarion revenue for the last year?▼
Aclarion revenue for the last year amounts to 92,000 USD.
What is Aclarion net income for the last year?▼
ACON net income for the last year is -13.99M USD.
How many employees does Aclarion have?▼
As of April 01, 2026, the company has 5 employees.
In which sector is Aclarion located?▼
Aclarion operates in the Health Care sector.
When did Aclarion complete a stock split?▼
The last stock split for Aclarion was on January 30, 2025 with a ratio of 1:335.